Literature DB >> 1985196

Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.

S H Cheng1, P C Espino, J Marshall, R Harvey, J Merrill, A E Smith.   

Abstract

Except for its unique amino-terminal region (residues 1 through 83), which possibly dictates substrate recognition, pp59c-fyn bears a high degree of homology with other members of the src family of tyrosine kinases. Here we show that the carboxy terminus of pp59c-fyn is necessary for stable middle-T-antigen association, that pp59c-fyn is normally phosphorylated on both serine and tyrosine residues, and that Tyr-531 and Tyr-420 are phosphorylation sites in vivo and in vitro, respectively. Analysis of a spontaneously generated mutant encoding a truncated form of pp59c-fyn and of variants specifically mutated at the Tyr-531 and Tyr-420 phosphorylation sites indicates that pp59c-fyn has regulatory elements analogous to those that have already been identified for other src-like tyrosine kinases. However, further examination of the pp59c-fyn variants suggests the likelihood of additional means by which its activities might be regulated. Although alteration of Tyr-531 to phenylalanine (531F) in pp59c-fyn results in a protein which is more active enzymatically that the wild type, the enhancement is much less than that for the analogous variant of pp60c-src. Furthermore, contrary to results of similar experiments on other src-like proto-oncogene products, 531F did not induce transformation of NIH 3T3 cells. Studies involving pp59c-fyn-pp60c-src chimeras in which the unique amino-terminal sequences (residues 1 through 83) of the two kinases were precisely interchanged implied that the inability of 531F to induce transformation is probably not caused by the absence of substrates for pp59c-fyn in NIH 3T3 cells but rather by the insufficient enhancement of pp59c-fyn kinase activity. It is therefore probable that the kinase and transforming activities of pp59c-fyn are repressed by additional regulatory elements possibly located in the amino-terminal half of the molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985196      PMCID: PMC240502     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.

Authors:  S H Cheng; H Piwnica-Worms; R W Harvey; T M Roberts; A E Smith
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

Review 2.  Specialized protein tyrosine kinase proto-oncogenes in hematopoietic cells.

Authors:  R M Perlmutter; J D Marth; S F Ziegler; A M Garvin; S Pawar; M P Cooke; K M Abraham
Journal:  Biochim Biophys Acta       Date:  1989-02

3.  Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.

Authors:  W M Potts; A B Reynolds; T J Lansing; J T Parsons
Journal:  Oncogene Res       Date:  1988

4.  p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen.

Authors:  R R Louie; C S King; A MacAuley; J D Marth; R M Perlmutter; W Eckhart; J A Cooper
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Acquisition of transforming properties by FYN, a normal SRC-related human gene.

Authors:  T Kawakami; Y Kawakami; S A Aaronson; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells.

Authors:  I D Horak; T Kawakami; F Gregory; K C Robbins; J B Bolen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

8.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells.

Authors:  R M Kypta; A Hemming; S A Courtneidge
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus.

Authors:  S H Cheng; R Harvey; P C Espino; K Semba; T Yamamoto; K Toyoshima; A E Smith
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  14 in total

1.  CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

Authors:  T Ishii; K Ohnuma; A Murakami; N Takasawa; S Kobayashi; N H Dang; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.

Authors:  R R Roussel; S R Brodeur; D Shalloway; A P Laudano
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

4.  Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.

Authors:  E Kremmer; K Ohst; J Kiefer; N Brewis; G Walter
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Functional interaction between the SH2 domain of Fyn and tyrosine 324 of hamster polyomavirus middle-T antigen.

Authors:  N M Dunant; A S Messerschmitt; K Ballmer-Hofer
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 6.  The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication.

Authors:  Horng D Ou; Andrew P May; Clodagh C O'Shea
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011 Jan-Feb

Review 7.  Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?

Authors:  Bianca Guglietti; Srisankavi Sivasankar; Sanam Mustafa; Frances Corrigan; Lyndsey E Collins-Praino
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

8.  Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II.

Authors:  W R Huckle; R C Dy; H S Earp
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Quantitative time-resolved phosphoproteomic analysis of mast cell signaling.

Authors:  Lulu Cao; Kebing Yu; Cindy Banh; Vinh Nguyen; Anna Ritz; Benjamin J Raphael; Yuko Kawakami; Toshiaki Kawakami; Arthur R Salomon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases.

Authors:  T R Hurley; R Hyman; B M Sefton
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.